Cargando…
Targeting nuclear import and export in hematological malignancies
The transport of proteins across the nuclear membrane is a highly regulated process, essential for the cell function. This transport is actively mediated by members of the karyopherin family, termed importins, or exportins, depending on the direction of transport. These proteins play an active part...
Autores principales: | Nachmias, Boaz, Schimmer, Aaron D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584478/ https://www.ncbi.nlm.nih.gov/pubmed/32624581 http://dx.doi.org/10.1038/s41375-020-0958-y |
Ejemplares similares
-
Selective inhibitors of nuclear export (SINE) in hematological malignancies
por: Das, Arundhati, et al.
Publicado: (2015) -
An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies
por: Goard, Carolyn A, et al.
Publicado: (2013) -
Applying CRISPR-Cas9 screens to dissect hematological malignancies
por: Iyer, Deepak Narayanan, et al.
Publicado: (2022) -
Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023) -
Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms
por: Balasubramanian, Suresh Kumar, et al.
Publicado: (2022)